Pembrolizumab vs Vancomycin

## Pembrolizumab vs Vancomycin: Overview

This comparison examines the pharmacological differences between **Pembrolizumab** and **Vancomycin**.

## Mechanism of Action

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

**Vancomycin**: Glycopeptide antibiotic inhibiting cell wall synthesis by binding D-Ala-D-Ala terminus of peptidoglycan precursors.

## Pharmacokinetics

**Half-life**: Pembrolizumab — 26 days; Vancomycin — 4-6 hours.

## Chemical Properties

**Molecular Formula**: Pembrolizumab — N/A; Vancomycin — C66H75Cl2N9O24.

**Molecular Weight**: Pembrolizumab — N/A; Vancomycin — 1449.2500 g/mol.

**Type**: Pembrolizumab — Antibody; Vancomycin — Small molecule.